Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

F2 Ventures

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 26
Average round size
info
The average size of a deal this fund participated in
$88M
Portfolio companies 15
Rounds per year 1.18
Lead investments 3
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.42
Exits 6
Key employees 1
Stages of investment
Early Stage Venture
Late Stage Venture

Areas of investment

  • Biotechnology
  • Therapeutics
  • Pharmaceutical
  • Health Care
  • Biopharma
Summary

In 2002 was created F2 Ventures, which is appeared as VC. The main office of represented VC is situated in the London. The fund was located in Europe if to be more exact in United Kingdom.

Among the various public portfolio startups of the fund, we may underline AlloVir, Cullinan Oncology, Cullinan Oncology Besides, a startup needs to be aged 4-5 years to get the investment from the fund. The fund has no exact preference in some founders of portfolio startups. When startup sums 3 or 4 of the founder, the probability for it to get the investment is little. Among the most popular fund investment industries, there are Pharmaceutical, Therapeutics. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States.

The typical case for the fund is to invest in rounds with 4-5 participants. Despite the F2 Ventures, startups are often financed by New York Angels, MPM Capital, Jerusalem Global Ventures. The meaningful sponsors for the fund in investment in the same round are MPM Capital, UBS Asset Management, Redmile Group. In the next rounds fund is usually obtained by Venturra Capital, MPM Capital, Cento Ventures.

We also calculated 1 valuable employee in our database.

Comparing to the other companies, this F2 Ventures performs on 12 percentage points less the average number of lead investments. Speaking about the real fund results, this VC is 3 percentage points less often commits exit comparing to other organizations. The common things for fund are deals in the range of 50 - 100 millions dollars. The fund is constantly included in less than 2 deals per year. The higher amount of exits for fund were in 2019. The important activity for fund was in 2015.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of F2 Ventures:
Typical Co-investors
F2 Ventures is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after F2 Ventures:

Funds with similar focus

Funds from United Kingdom
Funds with similar focus located in United Kingdom:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
AIP Private Markets -
Aligo Innovation Canada, Montréal, Quebec
Danone France, Ile-de-France, Paris
Fair by Design Fund England, London, United Kingdom
Gardiner Group Capital Canada, Ontario, Toronto
Hikari Tsushin Group Chiyoda, Japan
Hokuriku Bank Japan, Toyama, Toyama Prefecture
Huiruying Investment China, Guangdong Province, Huizhou
Jianxing Medical Fund China, Jianxing, Sichuan
Kilowatt Capital LLC California, San Francisco, United States
Mazor Robotics Caesarea, Hefa, Israel
Metdist England, London, United Kingdom
Millennium Life Sciences Fund Anaheim, California, United States
Network Solutions Herndon, United States, Virginia
Nordstjernan Stockholm, Stockholm County, Sweden
NTT-ME Japan, Toshima
TowerJazz Israel, Migdal Haemeq, North District
Yeling Chuangye Touzi Baoshan, China, Shanghai
Zhejiang Haining Yingchuang Equity Investment China, Haining, Zhejiang

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

ReNAgade Therapeutics

Biotechnology
Medical
Therapeutics
$300M23 May 2023 Cambridge, Massachusetts, United States

4M Analytics

Analytics
Artificial Intelligence
Consulting
Data Visualization
Database
Information Technology
Infrastructure
Machine Learning
Real Estate
Software
$30M20 Sep 2022 Herzliya, Tel Aviv, Israel

Justt

E-Commerce
Financial Services
Payments
$70M16 Nov 2021 Tel Aviv, Tel Aviv, Israel

Five Sigma

B2B
Insurance
InsurTech
Productivity Tools
SaaS
$12M13 Sep 2021 Tel Aviv, Tel Aviv, Israel

4M Analytics

Analytics
Artificial Intelligence
Consulting
Data Visualization
Database
Information Technology
Infrastructure
Machine Learning
Real Estate
Software
$11M09 Aug 2021 Herzliya, Tel Aviv, Israel

ElevateBio

Biotechnology
Genetics
Health Care
Therapeutics
$525M15 Mar 2021 Cambridge, Massachusetts, United States

Biotechnology
Medical
Pharmaceutical
Therapeutics
$80M24 Feb 2021 Cambridge, Massachusetts, United States

Cullinan Oncology

Biopharma
Biotechnology
Medical Device
$131M17 Dec 2020 Cambridge, Massachusetts, United States

Cullinan Oncology

Biopharma
Biotechnology
Medical Device
$98M04 Jun 2020 Cambridge, Massachusetts, United States
News
Parametrix Insurance raises $17.5 million to offer cloud downtime insurance

– Parametrix, a startup that offers insurance policies for companies that rely on third-party cloud providers, e-commerce services, payment gateways and CRM systems, raised $17.5m funding.
– The round was led by FirstMark Capital and F2 Venture Capital.
– The company offers insurance policies for companies that rely on third-party cloud providers, e-commerce services, payment gateways and CRM systems.
– It offers insurance policies for companies that rely on third-party cloud providers, e-commerce services, payment gateways and CRM systems.

ElevateBio Raises $525M in Series C Financing

– ElevateBio is a Cambridge, Mass.-based cell and gene therapy technology company focused on advancing new cell and gene therapies.
– Company raised $525m in Series C funding.
– The round was led by Matrix Capital Management with participation from new investors SoftBank Vision Fund 2 and Fidelity Management and Research Company and existing investors MPM Capital, F2 Ventures, Redmile Group, EcoR1 Capital, Samsara BioCapital, The Invus Group, Emerson Collective, Surveyor Capital (A Citadel company), EDBI, and Vertex Ventures, iTochu, and a large insurance company.

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent F2 Ventures?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 26
Average round size 88M
Rounds per year 1.18
Peak activity year 2021
Lead investments 3
Follow on index 0.42
Exits 6
Group Appearance index 1.00

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

ReNAgade Therapeutics

Biotechnology
Medical
Therapeutics
$300M23 May 2023 Cambridge, Massachusetts, United States

4M Analytics

Analytics
Artificial Intelligence
Consulting
Data Visualization
Database
Information Technology
Infrastructure
Machine Learning
Real Estate
Software
$30M20 Sep 2022 Herzliya, Tel Aviv, Israel

Justt

E-Commerce
Financial Services
Payments
$70M16 Nov 2021 Tel Aviv, Tel Aviv, Israel

Five Sigma

B2B
Insurance
InsurTech
Productivity Tools
SaaS
$12M13 Sep 2021 Tel Aviv, Tel Aviv, Israel

4M Analytics

Analytics
Artificial Intelligence
Consulting
Data Visualization
Database
Information Technology
Infrastructure
Machine Learning
Real Estate
Software
$11M09 Aug 2021 Herzliya, Tel Aviv, Israel

ElevateBio

Biotechnology
Genetics
Health Care
Therapeutics
$525M15 Mar 2021 Cambridge, Massachusetts, United States

Biotechnology
Medical
Pharmaceutical
Therapeutics
$80M24 Feb 2021 Cambridge, Massachusetts, United States

Cullinan Oncology

Biopharma
Biotechnology
Medical Device
$131M17 Dec 2020 Cambridge, Massachusetts, United States

Cullinan Oncology

Biopharma
Biotechnology
Medical Device
$98M04 Jun 2020 Cambridge, Massachusetts, United States
Crunchbase icon

Content report

The following text will be sent to our editors: